Status: Recruiting
A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)
The purpose of this study is to find out whether 177Lu-DPTA-omburtamab is a safe treatment for children and adolescents with recurrent/refractory medulloblastoma or another type of cancer with CNS metastases.
Participants needed: 18
Trial details
Phase: Phase 1Age: 3-22Biological sex: AllType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Jul 13, 2026Locations: 7
Eligibility criteria
Histologically confirmed diagnosis of a tumor that is known to express B7-H3 inc... [+25]
Patients with obstructive or symptomatic communicating hydrocephalus. [+3]